Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1993 | 1 |
1994 | 1 |
1995 | 1 |
2000 | 1 |
2001 | 1 |
2010 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Analysis of disease distribution, activity and complications in the patient with inflammatory bowel disease.
Scand J Gastroenterol Suppl. 1994;203:15-9. doi: 10.3109/00365529409091390.
Scand J Gastroenterol Suppl. 1994.
PMID: 7973442
Review.
Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.
Lichtenstein GR, Thomsen OØ, Schreiber S, Lawrance IC, Hanauer SB, Bloomfield R, Sandborn WJ; Precise 3 Study Investigators.
Lichtenstein GR, et al.
Clin Gastroenterol Hepatol. 2010 Jul;8(7):600-9. doi: 10.1016/j.cgh.2010.01.014. Epub 2010 Feb 1.
Clin Gastroenterol Hepatol. 2010.
PMID: 20117244
Clinical Trial.
Item in Clipboard
Perforation of toxic megacolon--the value of the plain radiograph.
Karlsson KA, Mwantembe OM.
Karlsson KA, et al. Among authors: mwantembe om.
S Afr Med J. 2000 Dec;90(12):1160.
S Afr Med J. 2000.
PMID: 11234632
No abstract available.
Item in Clipboard
Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.
Schreiber S, Colombel JF, Bloomfield R, Nikolaus S, Schölmerich J, Panés J, Sandborn WJ; PRECiSE 2 Study Investigators.
Schreiber S, et al.
Am J Gastroenterol. 2010 Jul;105(7):1574-82. doi: 10.1038/ajg.2010.78. Epub 2010 Mar 16.
Am J Gastroenterol. 2010.
PMID: 20234346
Clinical Trial.
Item in Clipboard
Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease.
Choudari CP, O'Mahony S, Brydon G, Mwantembe O, Ferguson A.
Choudari CP, et al. Among authors: mwantembe o.
Gastroenterology. 1993 Apr;104(4):1064-71. doi: 10.1016/0016-5085(93)90275-h.
Gastroenterology. 1993.
PMID: 8462795
Item in Clipboard
Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals.
Mwantembe O, Gaillard MC, Barkhuizen M, Pillay V, Berry SD, Dewar JB, Song E.
Mwantembe O, et al.
Immunogenetics. 2001;52(3-4):249-54. doi: 10.1007/s002510000265.
Immunogenetics. 2001.
PMID: 11220627
Item in Clipboard
Exploitation of the whole gut lavage technique for in vivo assessment of intestinal immunity and inflammation in inflammatory bowel disease.
Ferguson A, Choudari CP, Mwantembe O, Handy L.
Ferguson A, et al. Among authors: mwantembe o.
Adv Exp Med Biol. 1995;371B:1257-60.
Adv Exp Med Biol. 1995.
PMID: 7502795
No abstract available.
Item in Clipboard
Cite
Cite